Skip to main content
. 2019 Apr 30;15(3):570–579. doi: 10.5114/aoms.2019.84734

Table III.

Therapeutic efficacy data of different treatments in BALB/c mice bearing 4T1 tumor

Groups TTE, mean ± SD [days] TGD (%) MST [days] ILS (%)
Control 39 ±9 48
Vaccine 47 ±10 21.2 50 4.2
Doxil 60 ±4 53.8 ND ND
Combination 57 ±4 48.1 ND* ND

TTE – time to reach end point, TGD – tumor growth delay, MST – median survival time, ILS – increase of life span.

*

Not defined; survival did not reach below 50% at the determined time point, then median survival could not be computed